雜志介紹

European Journal Of Nuclear Medicine And Molecular Imaging雜志介紹

《European Journal Of Nuclear Medicine And Molecular Imaging》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱歐洲核醫(yī)學(xué)與分子成像雜志，本刊主要出版、報道醫(yī)學(xué)-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為8.6，最新CiteScore 指數(shù)為15.6。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

  Author: Salem, Riad; Padia, Siddharth A.; Lam, Marnix; Chiesa, Carlo; Haste, Paul; Sangro, Bruno; Toskich, Beau; Fowers, Kirk; Herman, Joseph M.; Kappadath, S. Cheenu; Leung, Thomas; Sze, Daniel Y.; Kim, Edward; Garin, Etienne

• Early detection of radiation-induced myocardial damage by [F-18]AlF-NOTA-FAPI-04 PET/CT imaging

  Author: Wei, Yuchun; Sun, Yuhong; Liu, Junyan; Zhang, Gongsen; Qin, Xueting; Xu, Shengnan; Wang, Shijie; Tao, Yuanyuan; Pei, Jinli; Yu, Jinming

• High in-vivo stability in preclinical and first-in-human experiments with [F-18]AlF-RESCA-MIRC213: a F-18-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers

  Author: Qin, Xue; Guo, Xiaoyi; Liu, Tianyu; Li, Liqiang; Zhou, Nina; Ma, Xiaopan; Meng, Xiangxi; Liu, Jiayue; Zhu, Hua; Jia, Bing; Yang, Zhi

• 9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice

  Author: Tian, Xiaofei; Wang, Chentai; Yu, Biao; Fan, Yixiang; Zhang, Lei; Zhang, Xin

英文介紹

European Journal Of Nuclear Medicine And Molecular Imaging雜志英文介紹

The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.

The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published.

The journal publishes the following article types:

Original article,

Review article,

Letter to the Editor,

Guidelines,

Controversies,

Image of the month,

Short Communications,

Editorials